More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Danish pharmaceutical company Novo Nordisk announced last weekend that Wegovy, the weight-loss version of the company's ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated. Among 25,531 participants in the National Health and Nutrition Examination ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...